Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT03887988

Orbital Fractures Registry

International, Multicenter, Prospective Registry to Collect Data on Orbital Fractures (OFx), Their Primary and Secondary Treatment and Outcome

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
AO Innovation Translation Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Approximately 300 patients presenting orbital blow-out fracture will be enrolled prospectively in this registry. All patients, surgically and nonsurgically treated as per standard (routine) of care will be followed-up (FU) within the registry for a period of 6 months.

Detailed description

Approximately 300 patients presenting with a displaced orbital fracture (OFx) in the floor and/or medial wall (blow-out fracture) will be enrolled prospectively in this registry. All patients, surgically and nonsurgical treated will be followed-up (FU) within the registry. FU period for all patients will include assessments post-treatment at 6 weeks, 3 months and 6 months as corresponding with the local standard (routine) visit schedule at each participating clinic. Data collection includes patient and fracture details, treatment details, functional, clinical and patient-reported outcomes and anticipated or procedure- and implant-related adverse events (ie, complications). Computer Tomography (CT) scans or Cone Beam-CT (CBCT) scans taken as per standard of care will be collected within the registry.

Conditions

Interventions

TypeNameDescription
PROCEDUREPrimary "early" reconstructionPrimary surgical reconstruction of the fracture within 3 weeks after injury
OTHERNonsurgicalNonsurgical treatment of fracture
PROCEDUREPrimary "delayed" reconstructionPrimary surgical reconstruction of the fracture more than 3 weeks after injury
PROCEDURESecondary reconstructionSecond surgical reconstruction of the fracture after a primary reconstruction.

Timeline

Start date
2019-11-01
Primary completion
2026-03-01
Completion
2026-03-01
First posted
2019-03-25
Last updated
2025-12-19

Locations

14 sites across 12 countries: United States, Germany, Netherlands, Pakistan, Qatar, Romania, Russia, Serbia, South Africa, Spain, Sweden, Switzerland

Source: ClinicalTrials.gov record NCT03887988. Inclusion in this directory is not an endorsement.